Browse the evidence

There is a significant and growing public interest in Ozempic and related GLP-1 agonists.

Healthcare providers should be prepared for increased inquiries about these medications.

Global mean intake of processed meat was 17 g/day, with mean national intakes of at least one serving per day for processed meat in countries representing 6.9% of the global population.

Health professionals should consider the prevalence of processed meat consumption in their dietary recommendations.

Significant gaps remain for achieving equity in nutrition security across the life span.

Efforts must be made to address gaps in nutrition security for all age groups.

The prevalences of type 2 diabetes and stroke mortality are higher in all Asian American subgroups compared with non-Hispanic White adults.

Health care professionals should prioritize screening for type 2 diabetes and stroke in Asian American populations.

Atherosclerotic cardiovascular disease risk is highest among South Asian and Filipino adults but lowest among Chinese, Japanese, and Korean adults.

Targeted interventions may be necessary for South Asian and Filipino populations to address higher cardiovascular risks.

Significant disproportionality for semaglutide remained in patients with coreported use of antidepressants and benzodiazepines.

Clinicians should consider the interaction of semaglutide with antidepressants and benzodiazepines when assessing risk.

To achieve nondominance, the annual price of semaglutide would need to be reduced from $13,618 to $3,591.

This suggests that pricing strategies for semaglutide could significantly impact its adoption in clinical practice.

The implementation of MTMs could potentially lead to net cost savings of $13.6 billion annually from a health care perspective.

Expanding coverage for MTMs could be a financially beneficial policy for healthcare systems.

The evidence for the benefits of power training on physical function and self-reported function was rated as low-certainty.

Practitioners should be aware of the limitations in the evidence when recommending power training.

A personalized diet targeting a reduction in postprandial glycemic response did not result in greater weight loss compared to a low-fat diet at 6 months.

Practitioners may consider that personalized diets based on PPGR may not provide superior weight loss outcomes compared to standard low-fat diets.

Increased residual gastric content was found in 40% of patients in the semaglutide group compared to 3% in the non-semaglutide group.

The significant difference in residual gastric content suggests that semaglutide may pose a risk during surgery, warranting careful assessment.

There is no consensus on the best nutritional strategy or ideal dietary prescription for the management of Type 2 Diabetes Mellitus (T2DM).

Practitioners should consider individual variability when recommending dietary strategies for T2DM.

GLP-1 receptor agonist use was associated with a higher risk of discontinuation of endoscopy compared to SGLT-2 inhibitors.

Practitioners should be aware of the increased risk of endoscopy discontinuation when using GLP-1 receptor agonists.

The cost needed to treat per 1% of body weight reduction with tirzepatide is estimated at $985 compared with $1845 with semaglutide.

Tirzepatide is more cost-effective for achieving weight loss in this population.

Machine learning techniques can enhance the ability to forecast obesity outcomes accurately.

Implementing machine learning can lead to better early detection and prediction of obesity.

More studies are needed to support the long-term effects of long-acting amylin analogues in relevant populations.

Practitioners should be aware that while promising, the long-term efficacy of these treatments is not yet established.

The analysis was limited to studies using dual-energy X-ray absorptiometry (DXA) for measuring fat-free mass.

Practitioners should be aware of the limitations of DXA in assessing body composition.

There is limited literature on the impact of weight loss medications for plastic surgeons and their patients.

Plastic surgeons need to seek more information on the effects of these medications.

Plastic surgeons must understand the indications, contraindications, and perioperative management of weight loss medications.

Surgeons should educate themselves on these medications to ensure safe practices.

There is much more variation in total, activity, and basal energy expenditure among males compared to females.

Practitioners should consider the greater variability in energy expenditure among males when designing interventions.

Variation in total energy expenditure decreases with aging, more rapidly in males.

Interventions may need to adjust for age-related changes in energy expenditure variability.

The consumption of saturated fat (SFA) is not significantly associated with cardiovascular disease (CVD) risk, events, or mortality.

Practitioners can consider including SFA from nutrient-dense foods in diets without fear of increasing CVD risk.

There is no scientific ground to demonize saturated fat as a cause of cardiovascular disease.

Health professionals can reassess dietary guidelines that restrict SFA without evidence of harm.

Beneficial effects of replacing saturated fat with polyunsaturated or monounsaturated fat or carbohydrates remain elusive.

Dietary recommendations should be cautious about promoting replacements for SFA without clear evidence of benefit.